SMRTe Antibodies

Santa Cruz Biotechnology offers a broad range of SMRTe monoclonal antibodies for targeting SMRTe protein. SMRTe monoclonal antibodies are validated for multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). SMRTe protein plays a crucial role in regulating gene expression and maintaining stem cell pluripotency, making it essential for developmental biology and regenerative medicine studies. Understanding SMRTe protein's involvement in cellular differentiation and proliferation provides valuable insights into various diseases, including cancer. SMRTe monoclonal antibodies enable precise detection and analysis of cellular pathways and molecular mechanisms. Researchers can effectively study SMRTe protein's role in normal development and disease progression. Advanced research techniques using SMRTe monoclonal antibodies help uncover new therapeutic targets. Santa Cruz Biotechnology monoclonal antibodies support scientific advancement by enabling researchers to make meaningful discoveries in cell biology and disease research.